COVID-19 long haulers
With the risks of drug development prohibitive, repurposed or repositioned medicines appear the best hope against long-COVID, a condition that still raises many unanswered questions.
Archives
Phage Therapy’s Latest Makeover
As issues of product consistency, standardization and specificity are being tackled, can phage therapeutics—long oversold and overhyped—finally realize their antibacterial potential?
Climate Anxiety
The existential threat posed by climate change is deeply troubling to many young people
Inflammation and Brain Health
Normally a guard against brain injury and infection, inflammation is increasingly being implicated in cognitive decline
The Virome Hunters
Ambitious efforts to catalog viruses across the globe may facilitate our understanding of viral communities and ecology, boost infectious disease diagnostics and surveillance, and spur new therapeutics.
Many Pediatric Studies Are a Waste of Time
New initiatives aim to lessen the obstacles to finding useful treatments for children